End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.35 CNY | -0.68% | +7.05% | +11.94% |
04-24 | Runben Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 1.35B 187M 254M | Sales 2025 * | 1.72B 238M 324M | Capitalization | 8.23B 1.14B 1.55B |
---|---|---|---|---|---|
Net income 2024 * | 287M 39.73M 54.09M | Net income 2025 * | 360M 49.84M 67.85M | EV / Sales 2024 * | 6.11 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 4.79 x |
P/E ratio 2024 * |
28.7
x | P/E ratio 2025 * |
22.9
x | Employees | 917 |
Yield 2024 * |
0.95% | Yield 2025 * |
1.18% | Free-Float | 15.26% |
1 day | -0.68% | ||
1 week | +7.05% | ||
Current month | +9.23% | ||
1 month | +28.15% | ||
3 months | +49.19% | ||
6 months | +15.43% | ||
Current year | +11.94% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 20.35 | -0.68% | 2,813,913 |
24-05-16 | 20.49 | +0.94% | 2,865,453 |
24-05-15 | 20.3 | +4.16% | 4,682,461 |
24-05-14 | 19.49 | +5.29% | 3,595,592 |
24-05-13 | 18.51 | -2.63% | 2,311,411 |
End-of-day quote Shanghai S.E., May 16, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 603193 Stock